Endothelin is a potent constrictor of human vessels used in coronary revascularization surgery
- 1 September 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 186 (2-3) , 311-314
- https://doi.org/10.1016/0014-2999(90)90450-k
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins.Circulation Research, 1990
- Differential sensitivity to endothelin in canine arteries and veinsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1989
- Influence of endothelin on human coronary arteries and localization of its binding sitesThe American Journal of Cardiology, 1989
- Human Vascular Responses to Endothelin-1Journal of Cardiovascular Pharmacology, 1989
- The Discovery, the Present State, and the Future Prospects of EndothelinJournal of Cardiovascular Pharmacology, 1989
- The Possible Role of Endothelin-1 in the Pathogenesis of Coronary VasospasmJournal of Cardiovascular Pharmacology, 1989
- Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.Proceedings of the National Academy of Sciences, 1988
- Difference between Endothelium-Dependent Relaxation in Arterial and in Venous Coronary Bypass GraftsNew England Journal of Medicine, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Cyclic guanosine monophosphate as a mediator of vasodilation.Journal of Clinical Investigation, 1986